{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T11:26:41Z","timestamp":1781954801450,"version":"3.54.5"},"reference-count":169,"publisher":"Impact Journals, LLC","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,9,12]]},"DOI":"10.18632\/oncotarget.18094","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T16:22:06Z","timestamp":1495556526000},"page":"66601-66619","source":"Crossref","is-referenced-by-count":24,"title":["Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?"],"prefix":"10.18632","volume":"8","author":[{"given":"Jolanta","family":"Ma\u0142yszko","sequence":"first","affiliation":[{"name":"Second Department of Nephrology and Hypertension with Dialysis Unit, Medical University of Bialystok, Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leszek","family":"Kozlowski","sequence":"additional","affiliation":[{"name":"Department of Oncological Surgery, Ministry of Interior Affairs, Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"Koz\u0142owska","sequence":"additional","affiliation":[{"name":"Second Department of Nephrology and Hypertension with Dialysis Unit, Medical University of Bialystok, Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Ma\u0142yszko","sequence":"additional","affiliation":[{"name":"Second Department of Nephrology and Hypertension with Dialysis Unit, Medical University of Bialystok, Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Ma\u0142yszko","sequence":"additional","affiliation":[{"name":"First Department of Nephrology and Transplantology with Dialysis Unit, Medical University of Bialystok, Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,5,23]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1681\/ASN.2012070690","article-title":"Onconephrology: the latest frontier in the war against kidney disease","volume":"24","author":"Bonventre","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0272-6386(98)70074-5","article-title":"Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey","volume":"32","author":"Agodoa","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000180813","article-title":"Increased incidence of malignancy in chronic renal failure","volume":"18","author":"Gabriel","year":"1977","journal-title":"Nephron"},{"key":"4","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ejim.2011.02.002","article-title":"Recent advances in diagnosis and treatment of acute kidney injury in patients with cancer","volume":"22","author":"Sabath","year":"2011","journal-title":"Eur J Intern Med"},{"key":"5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.semnephrol.2010.09.002","article-title":"Electrolyte disturbances and acute kidney injury in patients with cancer","volume":"30","author":"Vanholder","year":"2010","journal-title":"Semin Nephrol"},{"key":"6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2215\/CJN.03530412","article-title":"Incidence rate, clinical correlates, and outcomes of AKI in patients admitted to a comprehensive cancer center","volume":"8","author":"Shah","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"7","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00520-010-0978-7","article-title":"Small increases in serum creatinine are associated with prolonged ICU stay and increased hospital mortality in critically ill patients with cancer","volume":"19","author":"Shaw","year":"2011","journal-title":"Support Care Cancer"},{"key":"8","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1016\/j.ejca.2007.06.008","article-title":"Comorbidity in older surgical cancer patients: influence on patient care and outcome","volume":"43","author":"Coebergh","year":"2007","journal-title":"Eur J Cancer"},{"key":"9","first-page":"477","volume-title":"Cancer in the Elderly","author":"Muss","year":"2000"},{"key":"10","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1001\/archotol.134.10.1045","article-title":"The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer","volume":"134","author":"Piccirillo","year":"2008","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1014489911153","article-title":"Increased incidence of neoplasia in chronic renal failure (20-year experience)","volume":"33","author":"Cengiz","year":"2002","journal-title":"Int Urol Nephrol"},{"key":"12","unstructured":"National Cancer Institute. Surveillance Epidemiology and End Results: SEER stat fact sheets: All sites. Available at: http:\/\/seer.cancer.gov\/statfacts\/html\/all.html. Accessed January 16, 2017."},{"key":"13","unstructured":"National Cancer Institute: Find cancer statistics. Available at: www.cancer.gov\/statistics\/find. Accessed January 16, 2017."},{"key":"14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ejim.2011.05.005","article-title":"Incidence of acute kidney injury in cancer patients: a Danish population-based cohort study","volume":"22","author":"Sorensen","year":"2011","journal-title":"Eur J Intern Med"},{"key":"15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.suponc.2011.03.008","article-title":"Costs and outcomes of acute kidney injury in critically ill patients with cancer","volume":"9","author":"Salahudeen","year":"2011","journal-title":"J Support Oncol"},{"key":"16","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.2215\/CJN.03150312","article-title":"Onco-nephrology: tumor lysis syndrome","volume":"7","author":"Berns","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"17","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.2215\/CJN.03140312","article-title":"Onco-nephrology: AKI in the cancer patient","volume":"7","author":"Humphreys","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/ndt\/gfh637","article-title":"Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies","volume":"20","author":"Decruyenaere","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"19","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1097\/01.CCM.0000181728.13354.0A","article-title":"Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy","volume":"33","author":"Azoulay","year":"2005","journal-title":"Crit Care Med"},{"key":"20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/cc4907","article-title":"Clinical review: specific aspects of acute renal failure in cancer patients","volume":"10","author":"Azoulay","year":"2006","journal-title":"Crit Care"},{"key":"21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/MCC.0b013e32830ef70b","article-title":"Acute renal problems in the critically ill cancer patient","volume":"14","author":"Vanholder","year":"2008","journal-title":"Curr Opin Crit Care"},{"key":"22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/ckj\/sft135","article-title":"Nephrotoxicity of recent anti-cancer agents","volume":"7","author":"Lameire","year":"2014","journal-title":"Clin Kidney J"},{"key":"23","doi-asserted-by":"publisher","first-page":"e55870","DOI":"10.1371\/journal.pone.0055870","article-title":"Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival","volume":"8","author":"Azoulay","year":"2013","journal-title":"PLoS One"},{"key":"24","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1200\/JCO.2006.05.7869","article-title":"Prognosis of critically ill patients with cancer and acute renal dysfunction","volume":"24","author":"Spector","year":"2006","journal-title":"J Clin Oncol"},{"key":"25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1053\/j.ackd.2013.08.002","article-title":"Acute kidney injury in the cancer patient","volume":"21","author":"Okusa","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1681\/ASN.2004100843","article-title":"Renal failure associated with cancer and its treatment: an update","volume":"16","author":"Magee","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1056\/NEJM198102123040701","article-title":"Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy","volume":"304","author":"Kurtzman","year":"1981","journal-title":"N Engl J Med"},{"key":"28","article-title":"Nephrotoxicity of anticancer treatment","author":"Malyszko","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"29","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.kint.2016.05.024","article-title":"Checkmate: kidney injury associated with targeted cancer immunotherapy","volume":"90","author":"Perazella","year":"2016","journal-title":"Kidney Int"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw467","article-title":"Adverse kidney effects of epidermal growth factor receptor inhibitors","author":"Perazella","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw382","article-title":"Renal effects of immune checkpoint inhibitors","author":"Mathian","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"32","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1093\/annonc\/mdv136","article-title":"Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN)","volume":"26","author":"Sprangers","year":"2015","journal-title":"Ann Oncol"},{"key":"33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/CAD.0b013e3283161012","article-title":"Hypertension and proteinuria: a class-effect of antiangiogenic therapies","volume":"20","author":"Deray","year":"2009","journal-title":"Anticancer Drugs"},{"key":"34","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1200\/JCO.2012.42.8201","article-title":"Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen","volume":"30","author":"Tellier","year":"2012","journal-title":"J Clin Oncol"},{"key":"35","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Barisoni","year":"2008","journal-title":"N Engl J Med"},{"key":"36","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1053\/j.ajkd.2006.11.024","article-title":"Nephrotic syndrome after bevacizumab: case report and literature review","volume":"49","author":"Toto","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"37","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1016\/j.humpath.2014.05.015","article-title":"Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature","volume":"45","author":"Seshan","year":"2014","journal-title":"Hum Pathol"},{"key":"38","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1470-2045(07)70108-0","article-title":"Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective study","volume":"8","author":"Van Cutsem","year":"2007","journal-title":"Lancet Oncol"},{"key":"39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11523-009-0109-x","article-title":"Renal toxicity of targeted therapies","volume":"4","author":"Rixe","year":"2009","journal-title":"Target Oncol"},{"key":"40","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1172\/JCI31680","article-title":"Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia","volume":"117","author":"Bindels","year":"2007","journal-title":"J Clin Invest"},{"key":"41","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Antonia","year":"2012","journal-title":"N Engl J Med"},{"key":"42","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1200\/JCO.2009.26.7609","article-title":"Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates","volume":"28","author":"Selby","year":"2010","journal-title":"J Clin Oncol"},{"key":"43","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1056\/NEJMoa1305133","article-title":"Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma","volume":"369","author":"Patnaik","year":"2013","journal-title":"N Engl J Med"},{"key":"44","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ejca.2016.02.025","article-title":"Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy","volume":"60","author":"Tietze","year":"2016","journal-title":"Eur J Cancer"},{"key":"45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1053\/j.ajkd.2016.02.057","article-title":"Association of acute interstitial nephritis with programmed cell death 1 inhibitor therapy in lung cancer patients","volume":"68","author":"Gettinger","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"46","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMc0904283","article-title":"Anti-CTLA4 antibody-induced lupus nephritis","volume":"361","author":"Knebelmann","year":"2009","journal-title":"N Engl J Med"},{"key":"47","first-page":"4607","article-title":"Ipilimumab-induced immune-related renal failure--a case report","volume":"32","author":"O'Byrne","year":"2012","journal-title":"Anticancer Res"},{"key":"48","doi-asserted-by":"publisher","first-page":"e53745","DOI":"10.1371\/journal.pone.0053745","article-title":"The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network","volume":"8","author":"Grabbe","year":"2013","journal-title":"PLoS One"},{"key":"49","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1200\/JCO.2010.32.2206","article-title":"Resolution of severe ipilimumab-induced hepatitis after antithymocyte globulin therapy","volume":"29","author":"Kefford","year":"2011","journal-title":"J Clin Oncol"},{"key":"50","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.kint.2016.04.008","article-title":"Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors","volume":"90","author":"Stokes","year":"2016","journal-title":"Kidney Int"},{"key":"51","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1681\/ASN.V1261164","article-title":"Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate","volume":"12","author":"D'Agati","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"52","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1053\/j.ajkd.2006.02.189","article-title":"Nephrotic-range proteinuria following pamidronate therapy in a patient with metastatic breast cancer: mitochondrial toxicity as a pathogenetic concept?","volume":"47","author":"Grone","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"53","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/ndt\/gfg567","article-title":"Collapsing glomerulopathy induced by long-term treatment with standard-dose pamidronate in a myeloma patient","volume":"19","author":"Holtzman","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"54","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1186\/s12885-015-1536-y","article-title":"Collapsing focal segmental glomerulosclerosis following long-term treatment with oral ibandronate: case report and review of literature","volume":"15","author":"Gralow","year":"2015","journal-title":"BMC Cancer"},{"key":"55","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5414\/CNP67263","article-title":"Potential effect of zoledronate therapy in heavy proteinuria","volume":"67","author":"Kumar","year":"2007","journal-title":"Clin Nephrol"},{"key":"56","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1038\/sj.ki.5000368","article-title":"Contrast-induced nephropathy: definition, epidemiology, and patients at risk","author":"Nikolsky","year":"2006","journal-title":"Kidney Int Suppl"},{"key":"57","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/ki.1996.173","article-title":"Role of adenosine in the renal responses to contrast medium","volume":"49","author":"Saruta","year":"1996","journal-title":"Kidney Int"},{"key":"58","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00004424-198303000-00012","article-title":"Relationship of renal hemodynamic and functional changes following intravascular contrast to the renin-angiotensin system and renal prostacyclin in the dog","volume":"18","author":"Briscoe","year":"1983","journal-title":"Invest Radiol"},{"key":"59","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1681\/ASN.2006111216","article-title":"Viscosity of contrast media perturbs renal hemodynamics","volume":"18","author":"Persson","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"60","first-page":"292","article-title":"Doppler ultrasound--physical aspects","volume":"11","author":"Gill","year":"1987","journal-title":"Semin Perinatol"},{"key":"61","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1681\/ASN.V111177","article-title":"Contrast nephropathy","volume":"11","author":"Parfrey","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"62","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/(SICI)1099-1263(199909\/10)19:5<341::AID-JAT584>3.0.CO;2-U","article-title":"Influence of the viscosity of iodixanol on medullary and cortical blood flow in the rat kidney: a potential cause of nephrotoxicity","volume":"19","author":"Corot","year":"1999","journal-title":"J Appl Toxicol"},{"key":"63","doi-asserted-by":"crossref","first-page":"S485","DOI":"10.1016\/S1076-6332(05)80363-0","article-title":"Variability of platelet degranulation by different contrast media","volume":"3","author":"Michelson","year":"1996","journal-title":"Acad Radiol"},{"key":"64","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ctrv.2011.09.002","article-title":"Endothelial vascular toxicity from chemotherapeutic agents: preclinical evidence and clinical implications","volume":"38","author":"Papadimitriou","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"65","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00004424-199911000-00004","article-title":"Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia","volume":"34","author":"Brezis","year":"1999","journal-title":"Invest Radiol"},{"key":"66","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0272-6386(97)90212-2","article-title":"Oxidant mechanisms in toxic acute renal failure","volume":"29","author":"Shah","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"67","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1148\/115.2.329","article-title":"Osmotic nephrosis induced by water-soluble triiodinated contrast media in man. A retrospective study of 47 cases","volume":"115","author":"Michel","year":"1975","journal-title":"Radiology"},{"key":"68","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/rct.0b013e31802e29d9","article-title":"Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations","volume":"31","author":"Gottlieb","year":"2007","journal-title":"J Comput Assist Tomogr"},{"key":"69","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s00330-013-2996-6","article-title":"Incidence of contrast-induced nephropathy in hospitalised patients with cancer","volume":"24","author":"Ustundag","year":"2014","journal-title":"Eur Radiol"},{"key":"70","doi-asserted-by":"publisher","first-page":"414","DOI":"10.2214\/AJR.09.4150","article-title":"Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU","volume":"195","author":"Samuels","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"71","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1148\/radiol.12121460","article-title":"Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis","volume":"267","author":"Kallmes","year":"2013","journal-title":"Radiology"},{"key":"72","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1148\/radiol.13130775","article-title":"Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate","volume":"271","author":"Williamson","year":"2014","journal-title":"Radiology"},{"key":"73","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1148\/radiol.12121823","article-title":"Intravenous contrast material-induced nephropathy: causal or coincident phenomenon?","volume":"267","author":"Kallmes","year":"2013","journal-title":"Radiology"},{"key":"74","doi-asserted-by":"publisher","first-page":"e387","DOI":"10.1016\/j.ejrad.2013.04.029","article-title":"Contrast induced nephropathy in patients undergoing intravenous (IV) contrast enhanced computed tomography (CECT) and the relationship with risk factors: a meta-analysis","volume":"82","author":"Bipat","year":"2013","journal-title":"Eur J Radiol"},{"key":"75","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.semnephrol.2010.09.003","article-title":"Epidemiology of chronic kidney disease in cancer patients: lessons from the IRMA study group","volume":"30","author":"Launay-Vacher","year":"2010","journal-title":"Semin Nephrol"},{"key":"76","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF02850082","article-title":"Incidence of renal insufficiency in cancer patients","volume":"22","author":"Alici","year":"2005","journal-title":"Adv Ther"},{"key":"77","first-page":"CR209","article-title":"Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patients","volume":"10","author":"Deray","year":"2004","journal-title":"Med Sci Monit"},{"key":"78","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/cncr.22904","article-title":"Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study","volume":"110","author":"Deray","year":"2007","journal-title":"Cancer"},{"key":"79","doi-asserted-by":"publisher","first-page":"9559","DOI":"10.1200\/jco.2009.27.15","article-title":"Prevalence of renal insufficiency in cancer patients: data from the IRMA-2 study","volume":"27","author":"Launay-Vacher","year":"2009","journal-title":"J Clin Oncol"},{"key":"80","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report","volume":"80","author":"Eckardt","year":"2011","journal-title":"Kidney Int"},{"key":"81","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S1470-2045(06)70803-8","article-title":"Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study","volume":"7","author":"Russo","year":"2006","journal-title":"Lancet Oncol"},{"key":"82","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1038\/sj.bjc.6605979","article-title":"Cancer and renal insufficiency results of the BIRMA study","volume":"103","author":"Wildiers","year":"2010","journal-title":"Br J Cancer"},{"key":"83","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.urology.2010.11.050","article-title":"Prevalence of baseline chronic kidney disease in patients presenting with solid renal tumors","volume":"77","author":"Uzzo","year":"2011","journal-title":"Urology"},{"key":"84","first-page":"38","article-title":"Prevalence of anemia and chronic kidney disease in cancer patients: clinical significance for 1-year mortality","volume":"53","author":"Ando","year":"2011","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"85","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s10549-008-0131-1","article-title":"Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues","volume":"124","author":"Beuzeboc","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"86","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00408-008-9123-5","article-title":"Lung cancer and renal insufficiency: prevalence and anticancer drug issues","volume":"187","author":"Morere","year":"2009","journal-title":"Lung"},{"key":"87","doi-asserted-by":"publisher","first-page":"E83","DOI":"10.3816\/CGC.2009.n.029","article-title":"Drug management of prostate cancer: prevalence and consequences of renal insufficiency","volume":"7","author":"Oudard","year":"2009","journal-title":"Clin Genitourin Cancer"},{"key":"88","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000003728","article-title":"Renal function and all-cause mortality risk among cancer patients","volume":"95","author":"Mao","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"89","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1681\/ASN.2008090998","article-title":"Association of CKD and cancer risk in older people","volume":"20","author":"Craig","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"90","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/ndt\/gfr467","article-title":"Changes in causes of death and risk of cancer in Danish patients with autosomal dominant polycystic kidney disease and end-stage renal disease","volume":"27","author":"Strandgaard","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"91","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1681\/ASN.2013060604","article-title":"CKD and the risk of incident cancer","volume":"25","author":"Go","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"92","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","article-title":"Cancer in patients on dialysis for end-stage renal disease: an international collaborative study","volume":"354","author":"Boyle","year":"1999","journal-title":"Lancet"},{"key":"93","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Fleissner","year":"2011","journal-title":"JAMA"},{"key":"94","unstructured":"US Renal Data System, USRDS 2003 Annual Data Report: Atlas of end-stage renal disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003."},{"key":"95","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1053\/j.ajkd.2014.12.013","article-title":"Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009","volume":"65","author":"Brookhart","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"96","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1002\/cncr.28043","article-title":"Cumulative incidence of cancer after solid organ transplantation","volume":"119","author":"Engels","year":"2013","journal-title":"Cancer"},{"key":"97","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1093\/ndt\/gfr464","article-title":"Increased risk of cancer in chronic dialysis patients: a population-based cohort study in Taiwan","volume":"27","author":"Fang","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"98","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-016-0356-8","article-title":"Incidence and characteristics of chronic renal replacement therapy in patients with cancer: data from kidney and cancer registries in Basse-Normandie","author":"Launoy","year":"2016","journal-title":"J Nephrol"},{"key":"99","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after kidney transplantation","volume":"296","author":"Grulich","year":"2006","journal-title":"JAMA"},{"key":"100","first-page":"253","article-title":"Chronic kidney disease and cancer: a troubling connection","volume":"23","author":"Stengel","year":"2010","journal-title":"J Nephrol"},{"key":"101","doi-asserted-by":"crossref","first-page":"C367","DOI":"10.1152\/ajpcell.1994.266.2.C367","article-title":"Human kidney proximal tubules are the main source of plasma glutathione peroxidase","volume":"266","author":"Cohen","year":"1994","journal-title":"Am J Physiol"},{"key":"102","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/00041552-199311000-00005","article-title":"The immune system in end-stage renal disease","volume":"2","author":"Descamps-Latscha","year":"1993","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"103","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.2215\/CJN.00950208","article-title":"Aspects of immune dysfunction in end-stage renal disease","volume":"3","author":"Lindholm","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"104","first-page":"1654","article-title":"Effects of selenium supplementation on immune parameters in chronic uraemic patients on haemodialysis","volume":"10","author":"Albertazzi","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"105","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1159\/000081023","article-title":"Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study","volume":"24","author":"Martin","year":"2004","journal-title":"Am J Nephrol"},{"key":"106","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000189042","article-title":"Plasma glutathione peroxidase deficiency caused by renal dysfunction","volume":"73","author":"Moriuchi","year":"1996","journal-title":"Nephron"},{"key":"107","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/01635580802404188","article-title":"Selenium, folate, and colon cancer","volume":"61","author":"Sandler","year":"2009","journal-title":"Nutr Cancer"},{"key":"108","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/074823379100700407","article-title":"Reanalysis of epidemiological data for selenium anti-cancer activity","volume":"7","author":"Lange","year":"1991","journal-title":"Toxicol Ind Health"},{"key":"109","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/jnci\/djm038","article-title":"A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer","volume":"99","author":"Giovannucci","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"110","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.leukres.2012.04.017","article-title":"Erythropoietin: the swinging pendulum","volume":"36","author":"Mittelman","year":"2012","journal-title":"Leuk Res"},{"key":"111","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.bbcan.2010.04.002","article-title":"The role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells From clinic to bench - a critical review","volume":"1806","author":"Feldman","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"112","doi-asserted-by":"publisher","first-page":"604","DOI":"10.2215\/CJN.03931106","article-title":"Screening, diagnosis, and treatment of cancer in long-term dialysis patients","volume":"2","author":"Holley","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"113","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/082585970201800208","article-title":"Medical and ethical dilemmas when an advanced cancer patient discontinues dialysis","volume":"18","author":"Fainsinger","year":"2002","journal-title":"J Palliat Care"},{"key":"114","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1111\/j.1532-5415.2000.tb03145.x","article-title":"Withholding versus withdrawing life-sustaining treatment: patient factors and documentation associated with dialysis decisions","volume":"48","author":"Knaus","year":"2000","journal-title":"J Am Geriatr Soc"},{"key":"115","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1089\/109662103764978650","article-title":"The renal palliative care initiative","volume":"6","author":"Germain","year":"2003","journal-title":"J Palliat Med"},{"key":"116","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/ndt\/gfg606","article-title":"Death after withdrawal from dialysis: the most common cause of death in a French dialysis population","volume":"19","author":"Dupouet","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"117","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1053\/j.ackd.2013.07.005","article-title":"Decision-making in patients with cancer and kidney disease","volume":"21","author":"Swidler","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"118","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1046\/j.1442-2042.2000.00231.x","article-title":"Prostate cancer with multiple lung metastases in a hemodialysis patient","volume":"7","author":"Hata","year":"2000","journal-title":"Int J Urol"},{"key":"119","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1177\/089686080102100605","article-title":"Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis","volume":"21","author":"Krediet","year":"2001","journal-title":"Perit Dial Int"},{"key":"120","first-page":"5191","article-title":"Serum levels of prostate specific antigen in men on hemodialysis","volume":"20","author":"Jakse","year":"2000","journal-title":"Anticancer Res"},{"key":"121","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/sj.ki.5000073","article-title":"Glomerular filtration rate estimated by cystatin C among different clinical presentations","volume":"69","author":"Larson","year":"2006","journal-title":"Kidney Int"},{"key":"122","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00134-003-2078-3","article-title":"Defining acute renal failure: physiological principles","volume":"30","author":"Ronco","year":"2004","journal-title":"Intensive Care Med"},{"key":"123","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00004872-199917030-00002","article-title":"How to assess glomerular function and damage in humans","volume":"17","author":"Bruckner","year":"1999","journal-title":"J Hypertens"},{"key":"124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/ajkd.2003.50007","article-title":"Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey","volume":"41","author":"Levey","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"125","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Coresh","year":"2009","journal-title":"Ann Intern Med"},{"key":"126","first-page":"S24","article-title":"Chronic kidney disease and cardiovascular disease in the Medicare population","volume":"87","author":"Herzog","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"127","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/ki.1997.163","article-title":"Renal function in the elderly: impact of hypertension and cardiac function","volume":"51","author":"Ritz","year":"1997","journal-title":"Kidney Int"},{"key":"128","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1008370126227","article-title":"Serum creatinine and blood urea nitrogen over a six-year period in the very old. Creatinine and BUN in the very old","volume":"8","author":"Frishman","year":"1998","journal-title":"Geriatr Nephrol Urol"},{"key":"129","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/ndt\/gfi324","article-title":"Estimation of glomerular filtration rate in patients with normal serum creatinine undergoing primary PCI: is it really normal?","volume":"21","author":"Musial","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"130","unstructured":"Food and Drug Administration. Guidance for industry: Pharmacokinetics in patients with impaired renal function \u2014 Study design, data analysis, and impact on dosing and labeling. US Department of Health and Human Services, Rockville, MD 1998. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm072127.pdf."},{"key":"131","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1053\/j.ajkd.2013.07.008","article-title":"Reduced estimated GFR and cancer mortality","volume":"63","author":"Wong","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"132","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000323740","article-title":"Chronic kidney disease in cancer patients: an independent predictor of cancer-specific mortality","volume":"33","author":"Jung","year":"2011","journal-title":"Am J Nephrol"},{"key":"133","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s00268-013-2436-4","article-title":"Short-term and long-term outcomes after gastrectomy for gastric cancer in patients with chronic kidney disease","volume":"38","author":"Nakajima","year":"2014","journal-title":"World J Surg"},{"key":"134","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1097\/DCR.0b013e3182600db7","article-title":"Impact of chronic kidney disease on outcomes of surgical resection for primary colorectal cancer: a retrospective cohort review","volume":"55","author":"Watanabe","year":"2012","journal-title":"Dis Colon Rectum"},{"key":"135","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jss.2013.04.035","article-title":"Is chronic kidney disease an independent risk factor for mortality in breast cancer?","volume":"184","author":"Kim","year":"2013","journal-title":"J Surg Res"},{"key":"136","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.thromres.2014.04.002","article-title":"Chronic kidney disease in patients with cancer and its association with occurrence of venous thromboembolism and mortality","volume":"134","author":"Ay","year":"2014","journal-title":"Thromb Res"},{"key":"137","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/codi.12665","article-title":"Impact of chronic kidney disease on postoperative outcome following colorectal cancer surgery","volume":"16","author":"Kennedy","year":"2014","journal-title":"Colorectal Dis"},{"key":"138","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1200\/jco.2015.62.6341","article-title":"Effect of pretreatment renal function on treatment and clinical outcomes in the adjuvant treatment of older women with breast cancer: Alliance A171201, an Ancillary Study of CALGB\/CTSU 49907","volume":"34","author":"Muss","year":"2016","journal-title":"J Clin Oncol"},{"key":"139","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1600-0609.2011.01717.x","article-title":"Chronic kidney disease stage 5 as the prognostic complement of International Staging System for multiple myeloma","volume":"88","author":"Tzeng","year":"2012","journal-title":"Eur J Haematol"},{"key":"140","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejca.2006.11.004","article-title":"International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency","volume":"43","author":"Aapro","year":"2007","journal-title":"Eur J Cancer"},{"key":"141","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/j.1523-1755.2005.67131.x","article-title":"Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions","volume":"67","author":"Dangas","year":"2005","journal-title":"Kidney Int"},{"key":"142","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/annonc\/mds344","article-title":"Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) study","volume":"24","author":"Deray","year":"2013","journal-title":"Ann Oncol"},{"key":"143","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1093\/ndt\/gfh807","article-title":"Clinical course of haemodialysis patients with malignancies and dose-adjusted chemotherapy","volume":"20","author":"Rasche","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"144","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2165\/00003088-197601020-00004","article-title":"Drug dosage in renal disease","volume":"1","author":"Dettli","year":"1976","journal-title":"Clin Pharmacokinet"},{"key":"145","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1056\/NEJM199408113310606","article-title":"Renal transplantation","volume":"331","author":"Strom","year":"1994","journal-title":"N Engl J Med"},{"key":"146","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Port","year":"1999","journal-title":"N Engl J Med"},{"key":"147","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2016.60337","article-title":"Comorbidities on kidney transplantation waiting list relative to the status of the potential recipient","author":"Malyszko","year":"2016","journal-title":"Arch Med Sci"},{"key":"148","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","article-title":"Cancer in patients on dialysis for end-stage renal disease: an international collaborative study","volume":"354","author":"Boyle","year":"1999","journal-title":"Lancet"},{"key":"149","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5301\/ijao.5000203","article-title":"Incidence and prevalence of cancer in kidney transplantation waiting list patients: an Italian experience","volume":"36","author":"Stefoni","year":"2013","journal-title":"Int J Artif Organs"},{"key":"150","first-page":"3","article-title":"The evaluation of renal transplantation candidates: clinical practice guidelines","volume":"1","author":"Weir","year":"2001","journal-title":"Am J Transplant"},{"key":"151","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1503\/cmaj.051291","article-title":"Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation","volume":"173","author":"Cole","year":"2005","journal-title":"CMAJ"},{"key":"152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1681\/ASN.V611","article-title":"The evaluation of renal transplant candidates: clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians","volume":"6","author":"Murphy","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"153","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/01.tp.0000260765.41275.e2","article-title":"A report of the Lisbon Conference on the care of the kidney transplant recipient","volume":"83","author":"Josephson","year":"2007","journal-title":"Transplantation"},{"key":"154","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/ndt\/gfu216","article-title":"European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care","volume":"30","author":"Steiger","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"155","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/TP.0b013e3182637078","article-title":"Clinical practice guidelines on wait-listing for kidney transplantation: consistent and equitable?","volume":"94","author":"Tong","year":"2012","journal-title":"Transplantation"},{"key":"156","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1053\/j.ajkd.2007.08.010","article-title":"Evaluation of adult kidney transplant candidates","volume":"50","author":"Danovitch","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"157","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0041-1345(00)02698-1","article-title":"Recurrence of cancer after renal transplantation","volume":"33","author":"Disney","year":"2001","journal-title":"Transplant Proc"},{"key":"158","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/1097-0142(19931001)72:7<2186::AID-CNCR2820720720>3.0.CO;2-2","article-title":"Clinical course of malignancies in renal transplant recipients","volume":"72","author":"Penn","year":"1993","journal-title":"Cancer"},{"key":"159","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/00007890-199304000-00011","article-title":"The effect of immunosuppression on pre-existing cancers","volume":"55","author":"Penn","year":"1993","journal-title":"Transplantation"},{"key":"160","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/01.TP.0000140845.10630.4F","article-title":"Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma","volume":"78","author":"Gross","year":"2004","journal-title":"Transplantation"},{"key":"161","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Fleissner","year":"2011","journal-title":"JAMA"},{"key":"162","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/ki.2013.458","article-title":"Malignancy-related mortality following kidney transplantation is common","volume":"85","author":"Sharif","year":"2014","journal-title":"Kidney Int"},{"key":"163","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1111\/j.1600-6143.2009.02728.x","article-title":"Cancer mortality in kidney transplantation","volume":"9","author":"Gill","year":"2009","journal-title":"Am J Transplant"},{"key":"164","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/jamaoncol.2015.5137","article-title":"Cancer mortality among recipients of solid-organ transplantation in Ontario, Canada","volume":"2","author":"Baxter","year":"2016","journal-title":"JAMA Oncol"},{"key":"165","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/TP.0000000000001192","article-title":"Outcomes of solid organ transplant recipients with preexisting malignancies in remission: a systematic review and meta-analysis","volume":"101","author":"Baxter","year":"2017","journal-title":"Transplantation"},{"key":"166","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/ajt.13978","article-title":"Cancer screening recommendations for solid organ transplant recipients: a systematic review of clinical practice guidelines","volume":"17","author":"Baxter","year":"2017","journal-title":"Am J Transplant"},{"key":"167","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5301\/jo-n.5000006","article-title":"Immune checkpoint inhibitors in the cancer patient with an organ transplant","volume":"1","author":"Jhaveri","year":"2017","journal-title":"J Onconephrol"},{"key":"168","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/ajt.12969","article-title":"Sirolimus use and cancer incidence among US kidney transplant recipients","volume":"15","author":"Segev","year":"2015","journal-title":"Am J Transplant"},{"key":"169","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jacr.2008.09.014","article-title":"In emergency situations, should serum creatinine be checked in all patients before performing second contrast CT examinations within 24 hours?","volume":"6","author":"Kaewlai","year":"2009","journal-title":"J Am Coll Radiol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.18094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T18:08:02Z","timestamp":1692814082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.18094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,23]]},"references-count":169,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2017,9,12]]}},"alternative-id":["18094","29029541"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.18094","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,23]]}}}